Search This Blog

Wednesday, June 6, 2018

Medicines Co. started at buy by B. Riley


The Medicines Co. initiated with a Buy at B. Riley FBR. B. Riley FBR analyst Madhu Kumar started The Medicines Co. with a Buy rating and $55 price target. The analyst believes the company has a “disruptive” cholesterol drug with “de-risked safety.”
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)